Patents
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
11/2001
11/13/2001US6316442 Treatment of heart disease and cerebrovascular disturbances
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313173 Glyoxylic acid amides
11/01/2001WO2001081324A1 Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties
11/01/2001WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
10/2001
10/31/2001EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/24/2001CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001US20010031730 Method for treatment of glutamate related disorders
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/10/2001CN1072655C New Heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical composition containing their
10/04/2001WO2001072725A1 BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa
10/04/2001WO2001072707A2 Carbamate caspase inhibitors and uses thereof
10/04/2001US20010027201 Non-systemic control of parasites
10/04/2001US20010027198 Novel heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
10/04/2001EP1138745A1 Organic electroluminescent element
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
09/2001
09/27/2001WO2001017972A3 Novel herbicides
09/27/2001US20010024749 Surface modified carbonaceous materials
09/26/2001EP1135379A1 Antitumor dibenzofluorene derivatives
09/26/2001EP0934252B1 Amide derivatives and their use as pesticides
09/26/2001EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors
09/19/2001CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta
09/19/2001CN1071327C Denzothiazine dioxides as endothelin antagonists
09/13/2001US20010021716 Using agonist of nicotinergic acetylcholine receptors
09/04/2001US6284767 Retroviral protease inhibiting compounds
09/04/2001US6284279 Less dust
08/2001
08/30/2001US20010018437 Using a thiomorpholinone compound
08/29/2001CN1310721A Medicine nitrate salts
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/28/2001US6281208 E.g., 3,4-dihydro-2-(5-methoxy-2-(3-(n-methyl-n-(2-((3,4-methylenedi oxy) phenoxy)ethyl)amino)propoxy)phenyl)-4-methyl-3-oxo-2h-1,4-benz
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001DE10032137A1 Verfahren zur Herstellung von Phenothiazin-Granulat mit verbesserten Eigenschaften Process for the preparation of phenothiazine granules having improved properties
08/22/2001EP1124807A1 Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
08/22/2001EP0973383A4 Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
08/22/2001CN1309634A Hydrazine derivs.
08/21/2001US6277990 For therapy of systemic and local inflammatory conditions.
08/16/2001EP1123279A1 New compounds, their preparation and use
08/15/2001CN1308069A Substittued (dihydro)benzoxazole and (dihydro)benzoxazine compound and their preparation and medicine composite
08/09/2001US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/08/2001CN1307571A Guanidine derivatives
08/02/2001WO2001054696A1 In vivo stain compounds and methods of use to identify dysplastic tissue
08/02/2001WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands
08/02/2001CA2366759A1 In vivo stain compounds and methods of use to identify dysplastic tissue
08/01/2001CN1306525A Carboxylic acid of aza-heterocyclic compounds contg. multiple hetero-atoms or its electronic isosteric object
07/2001
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/24/2001US6265583 Cyclic sulfone containing retroviral protease inhibitors
07/24/2001US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders
07/24/2001US6265401 Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
07/24/2001US6265399 Alkylation; cyclization
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/12/2001WO2001049670A1 5,10-dihydroacridines as calcium channel blockers
07/12/2001US20010007904 Process for manufacture of in vivo stain composition
07/12/2001CA2394199A1 5,10-dihydroacridines as calcium channel blockers
07/11/2001EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines
07/05/2001WO2001047902A1 Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide
07/05/2001WO2001047888A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use
06/2001
06/27/2001EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
06/27/2001CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors
06/26/2001US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound
06/26/2001US6251830 Pesticides and herbicides
06/26/2001US6251581 Mixture of suspendable particles, one type is chemiluminescent compound capable of reacting with singlet oxygen, the other type is photosensitizer which is capable of activating oxygen to its singlet state
06/20/2001EP0890176B1 Proton conductor in liquid form
06/19/2001USRE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
06/14/2001WO2001042219A2 Novel substituted phenanthridinones and methods of use thereof
06/14/2001WO2001042211A2 Detection of transmembrane potentials by optical methods
06/14/2001WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
06/14/2001US20010003747 Useful in treating or in preventing melatoninergic disorders
06/14/2001CA2393567A1 Novel substituted phenanthridinones and methods of use thereof
06/14/2001CA2393562A1 Detection of transmembrane potentials by optical methods
06/13/2001EP1106608A1 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine derivatives, process for their preparation and pharmaceutical compositions containing them
06/12/2001US6245811 Fatty acid esters as bioactive compounds
06/12/2001CA2080917C New pharmacologically active catechol derivatives
06/08/2001WO2001040208A2 Process for synthesis of 4-hydroxy-2h-1,2-benzothiazine-3-carboxamides
06/07/2001WO2001040209A1 Phenothiazines in prill form
06/07/2001WO2001040202A1 (hetero)aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insecticides
06/07/2001WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/07/2001DE19958164A1 Aryl-substituierte heterozyklische Enaminone Aryl-substituted heterocyclic Enaminones
06/07/2001CA2394002A1 (hetero)aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insecticides
06/07/2001CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/06/2001EP1104412A1 Tace inhibitors
06/06/2001EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
06/06/2001EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders
06/06/2001CN1298390A Arylphenyl-substituted cyclic keto-enols
06/06/2001CA2328553A1 Novel derivatives (dihydro)benzoxazine and (dihydro)benzothiazine substitutes, process for preparing them and pharmaceutical compositions containing them
05/2001
05/30/2001EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/29/2001US6239151 Compounds as inhibitor of tumor necrosis factor alpha release
05/25/2001WO2001036426A1 Pyridinones to treat and prevent bacterial infections
05/25/2001CA2390658A1 Pyridinones to treat and prevent bacterial infections
05/23/2001EP1100805A1 Medicine nitrate salts
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 52